My.Alpha Management Hk Advisors LTD Hutchmed (China) LTD Transaction History
My.Alpha Management Hk Advisors LTD
- $88.6 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding HCM
# of Institutions
60Shares Held
5.97MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.58MShares$38.6 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M909KShares$13.6 Million0.02% of portfolio
-
State Street Corp Boston, MA329KShares$4.92 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.72 Million0.11% of portfolio
-
Goldman Sachs Group Inc New York, NY289KShares$4.32 Million0.0% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.59B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...